Current Report Filing (8-k)
2021年9月11日 - 6:17AM
Edgar (US Regulatory)
DE false 0001837997 0001837997 2021-09-08 2021-09-08 0001837997 us-gaap:CommonStockMember 2021-09-08 2021-09-08 0001837997 us-gaap:WarrantMember 2021-09-08 2021-09-08
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): September 8, 2021
ISLEWORTH HEALTHCARE ACQUISITION CORP.
(Exact Name of Registrant as Specified in its Charter)
|
|
|
|
|
DELAWARE
|
|
001-40104
|
|
86-1216057
|
(State or Other Jurisdiction of
Incorporation or Organization)
|
|
(Commission
File No.)
|
|
(I.R.S. Employer
Identification No.)
|
360 Central Avenue, First Central Tower, Suite 800,
St. Petersburg, Florida 33716
(Address of principal executive offices and zip code)
(727) 245-0146
(Registrant’s telephone number, including area code)
(Former name or former address, if changed from last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-14(c)).
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
|
Title of each class
|
|
Trading
Symbol (s)
|
|
Name of each exchange
on which registered
|
Common Stock, par value $0.0001 per share
|
|
ISLE
|
|
The NASDAQ Stock Market LLC
|
Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50 per whole share
|
|
ISLEW
|
|
The NASDAQ Stock Market LLC
|
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On September 8, 2021, Marc Kozin resigned as a member of the Board of Directors of Isleworth Healthcare Acquisition Corporation (the “Company”). Mr. Kozin’s decision to resign was not a result of any disagreement with the Company.
On September 8, 2021, the Board of Directors of the Company appointed Dr. Monica Reed as an independent member of the Company’s Board of Directors, effective on such date. Dr. Reed was also appointed to serve on the Board’s audit committee.
2
SIGNATURE
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
ISLEWORTH HEALTHCARE ACQUISITION CORP.
|
|
|
By:
|
|
/s/ Dan Halvorson
|
|
|
Dan Halvorson
|
|
|
Chief Financial Officer
|
Dated: September 10, 2021
3
Isleworth Healthcare Acq... (NASDAQ:ISLEU)
過去 株価チャート
から 8 2024 まで 10 2024
Isleworth Healthcare Acq... (NASDAQ:ISLEU)
過去 株価チャート
から 10 2023 まで 10 2024
Real-Time news about Isleworth Healthcare Acquisition Corporation (ナスダック市場): 0 recent articles
その他のIsleworth Healthcare Acquisition Corp.ニュース記事